Neurology Minute

In the final episode of this three-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the PINGS-2 Trial, which was presented at the 2025 European Stroke Organization Conference. Show reference:  https://eso-stroke.org/wp-content/uploads/Curtain-Raiser-2-1.pdf  

In part two of this three-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the OPTIMISTmain Trial, which was presented at the 2025 European Stroke Organization Conference. Show reference:  https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00549-5/abstract 

In part one of this three-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the BRIDGE-TNK Trial, which was presented at the 2025 European Stroke Organization Conference. Show reference:  https://www.nejm.org/doi/full/10.1056/NEJMoa2503867    

Dr. Elizabeth Coon and Dr. Peter Novak discuss how central sensitization plays a role in the autonomic symptoms-sings dichotomy and the importance of addressing both conditions for optimal treatment. Show references:  https://www.neurology.org/doi/10.1212/CPJ.0000000000200463  

In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Jean Holowach-Thurston. 

In the second installment of this two-part series, Dr. Jeff Ratliff and Dr. Brin E. Freund discuss clinical guidance for managing patients who may experience neurotoxicity from CAR T-cell, with a specific focus on seizure risk.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000213535  

In the June episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss advocacy opportunities.  Show reference:  https://www.aan.com/about-the-aan/presidents-spotlight  

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Brin E. Freund discuss the incidence of acute symptomatic seizures during CAR T-cell therapy.  Show reference:  https://www.neurology.org/doi/10.1212/WNL.0000000000213535    

Dr. Halley Alexander and Dr. Serena Yin discuss the effectiveness of an electronic medical record best practice alert in preventing iatrogenic interventions for patients with a diagnosis of PNES. Show references:  https://www.neurology.org/doi/10.1212/CPJ.0000000000200457  

In the first episode of this new series, Dr. Andy Southerland discusses the June updates from the AAN's Capitol Hill Report (CHR). This month's CHR update includes a member story from Dr. José Posas.  Stay updated with what's happening on the hill by visiting  aan.com/chr .  Learn how you can  get involved with AAN advocacy. 

Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis.  Show reference:  https://www.nejm.org/doi/full/10.1056/NEJMoa2501561

In the final installment of this three-part series, Dr. Elizabeth Zollos discusses another important diagnostic tool, visually evoked potentials or VEP.

Dr. Halley Alexander and Dr. Samuel W. Terman discuss patients' perceived seizure risk, seizure risk tolerance, and risk counseling techniques.  Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200475  

Dr. Katie Krulisky and Dr. Leah Blank discuss the impact of outpatient follow-up on readmission rates for older adults with epilepsy or seizures.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213638  

In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss his team's findings on the treatment approach presented in this paper.  Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397   

In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss how patients with amyloid-beta–related angiitis present.  Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397    

In the concluding segment of this series, Dr. Halley Alexander and Dr. Coral M. Stredny delve into the essential components of seizure action plans and identify the individuals who should have one. Show reference:  https://www.neurology.org/doi/10.1212/CPJ.0000000000200449   

In part one of this two-part series, Dr. Halley Alexander and Dr. Coral M. Stredny discuss the importance of seizure action plans and how this might translate into our clinical care.  Show reference:  https://www.neurology.org/doi/10.1212/CPJ.0000000000200449    

Dr. Nadia Khalil and Dr. Jean Bouchart discuss the diagnostic approach to intracerebral hemorrhage, the causes of cerebral small vessel disease, and the interpretation of biomolecular tests.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209796  

In the final episode of this three-part series, Dr. Jodie Roberts and Dr. Urs Fisch discuss functional/dissociative seizures and driving risk.  Learn more about the  Neurology ®  Practice Current  section and fill out the current survey on  functional/dissociative seizures and driving . 

In part two of this three-part series, Dr. Jodie Roberts and Dr. Barbara A. Dworetzky discuss how often seizure-like or seizure-resembling episodes lead to a diagnosis of functional neurologic disorder.  Learn more about the  Neurology ®  Practice Current  section and fill out the current survey on  functional/dissociative seizures and driving . 

In part one of this three-part series, Dr. Jodie Roberts and Dr. Barbara A. Dworetzky discuss the term "functional seizures" and clarify the terminology.  Learn more about the Neurology ® Practice Current section and fill out the current survey on functional/dissociative seizures and driving . 

In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss small vessel primary CNS vasculitis. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397  

Dr. Greg Cooper and Dr. David A. Wolk discuss limbic predominant age-related TDP-43 encephalopathy (LATE), covering its clinical features, diagnostic criteria, and more. Show reference: https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.14202    

In the second installment of this three-part series, Dr. Elizabeth Zollos discusses the use of magnetic resonance imaging (MRI) in multiple sclerosis diagnosis.